Romania - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Romania Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry fell by 7.3% year on year. In 2019, the country was ranked number 30 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry with $26,524,562.71 Million PPP. Romania is overtaken by Chile, which was number 29 at $28,786,954.1 Million PPP and is followed by Slovakia with $4,291,243.82 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, that is an increase of 3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
Date | Million US Dollars PPP |
---|---|
2019 | 26,524,562.71 |
2018 | 26,181,292.20 |
2017 | 21,068,593.57 |
2016 | 36,967,447.64 |
2015 | 27,886,435.88 |
How does Romania rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
# | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
29 |
#29
Chile
|
28,786,954.10 | 2015 | +2.7 % | +15.9 % | View data | |
30 |
#30
Romania
|
26,524,562.71 | 2019 | +1.3 % | -7.3 % | View data | |
31 |
#31
Slovakia
|
4,291,243.82 | 2019 | -17.4 % | -13.2 % | View data |